Cancer-related fatigue in adolescents and young adults: A systematic review of the literature

Nowe, Erik; Stöbel-Richter, Yve; Sender, Annekathrin; Leuteritz, Katja; Friedrich, Michael; Geue, Kristina

doi:10.1016/j.critrevonc.2017.08.004

Cited by 58 publications

(62 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the IV stage of melanoma (distant metastases), the global quality of life depends on the type of applied therapy, its side effects and the prevalence and localization of metastases. Our results are in accordance with other studies where the global quality of life is low in the IV stage of the disease, too (22)(23)(24). The low level of global quality of life in the IV stage of melanoma was more than twice lower than in the I and II stage of the disease.…”

Section: Discussionsupporting

confidence: 93%

“…We could explain our results with the fact that the overall global quality of life is decreasing during the time, because of the progression of the malignant disease that affected the complication of everyday functioning, including some financial difficulties and symptomatology, considered primarily fatigue, nausea and vomiting, pain, dyspnoea, insomnia, appetite loss, constipation, diarrhea etc. (24)(25)(26)(27)(28)(29). The data obtained in our study are in accordance with the data obtained in other surveys that support the declining functioning of melanoma as well as the global quality of life as the symptomology grows (30)(31)(32).…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Depression, anxiety and quality of life in patients with melanoma

Vojvodić

Dedić

2020

VOJNOSANIT PREGL

View full text Add to dashboard Cite

Background / Aim. Recent investigations have established a significant correlation between melanoma and quality of life, as well as anxiety and depression in these patients. In prognosis of melanoma, the most important is the stage in which it is diagnosed. The objective of our study was to analyze the quality of life, anxiety and depression in patients with a diagnosis of melanoma at different stages of the disease. Methods. In our crosssectional study were included 40 consecutive patients with melanoma at diagnosis, which are diagnosed and treated at Department of Dermatology and Venerology Military Medical Academy during the period from October to November 2015. 20 respondents are in stage I and stage II (localized disease) and 20 respondents in stage IV (distant metastases). In our investigation we used EORTC Quality of Life Questionnaire (EORTC QLQ 30), Beck anxiety inventory (BAI) and Beck depression inventory (BDI). The statistical analysis included parametric and non-parametric descriptive statistics. Results. In stage I and II anxiety scores were higher in comparison to stage IV disease patients (37.5 vs 14.5, p<0.05), but depression was more pronounced (6 vs 2.5, p<0.05) in IV stage. There are statistically significant differences in all segments of quality of life between patients that are in I and II stage and patients in IV stage of the disease. The global quality of life was significantly worse for patients in the IV stage (33.5 vs 83), the symptomatology is more pronounced (78.5 vs 0) and the functioning was significantly worse (31 vs 85) in relation to patients at the I and II stages (p<0.01) for all segments of quality of life. Conclusion. Anxiety and quality of life decrease, while depression increases with the stage of melanoma. The need for adequate social and family support as well as psychological assistance in order to achieve better coping with illness is necessary in patients with melanoma. Further studies are needed for monitoring of anxiety, depression and quality of life from the moment of diagnosis of the disease over time, as well as the impact of new treatment modalities on these parameters. Key words: melanoma, depression, anxiety, quality of life, psychological instrument.Apstrakt Uvod / Cilj. Nedavna istaživanja su pokazala značajnu korelaciju između melanoma i kvaliteta života, kao i anksioznosti i depresije kod ovih pacijenata. U prognozi melanoma, najvažnija je faza u kojoj je dijagnostikovan. Cilj naše studije bila je analiza kvalitet života, anksioznosti i depresije kod pacijenata sa dijagnozom melanoma u različitim stadijumima bolesti. Metode. U našoj studiji preseka su bili uključeni pacijenati dijagnostikovani i lečeni u Klinici za kožne i polne bolesti Vojnomedicinske akademije tokom perioda od oktobra do decembra 2015. godine, ukupno 40 pacijenata sa dijagnozom melanoma. 20 ispitanika je bilo u I i II stadijumu (lokalizovane bolesti) i 20 ispitanika u IV fazi (udaljene metastaze). U našem istraživanju koristili smo upitnik za procenu kvalitet života obolelih od melanoma...

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussionsupporting

confidence: 91%

Depression, anxiety and quality of life in patients with melanoma

Vojvodić

Dedić

2020

VOJNOSANIT PREGL

View full text Add to dashboard Cite

show abstract

“…YACSs are, therefore, likely to experience survivorship challenges different from those described among older adult or childhood cancer survivors [2]. Still, limited knowledge exists about late effects following curative cancer treatment in YACSs [2,3].…”

Section: Introductionmentioning

confidence: 99%

Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood

et al. 2019

View full text Add to dashboard Cite

Background: Chronic fatigue (CF) is scarcely explored among young adult cancer survivors (YACSs), and more knowledge is needed to develop targeted interventions for YACSs with CF. The present study aimed to investigate the prevalence of CF and associated factors in YACSs. Also, the change of fatigue with time was explored. Material and methods: The present cross-sectional study is part of a nationwide population based survey of Norwegian survivors of cancer in childhood, adolescence, and young adulthood (The NOR-CAYACS study).YACSs diagnosed at the age of 19-39 years with breast cancer stage III (BC), colorectal cancer (CRC), non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia, or non-metastatic malignant melanoma (MM) were included 5-30 years after diagnosis. Survivors of MM treated with limited surgery were included as a reference group. CF was assessed by the Fatigue Questionnaire. Logistic regression analyses were performed to identify factors associated with CF. Results: In total, 1488 survivors completed the questionnaire (a response rate of 42%), of which 1088 were eligible for the present study. Overall, 25% reported CF. CF was significantly more prevalent among survivors of BC (29%) (p < .001), CRC (29%) (p ¼ .001) and NHL (27%) (p ¼ .003) than among survivors of MM (15%). CF was associated with systemic treatment combined with surgery and/or radiotherapy (p ¼ .018), comorbidity (p ¼ .038), pain (p ¼ .002), numbness in hands/feet (p ¼ .046), and depressive symptoms (p < .001) in the multivariable model. Among survivors with CF, 60% reported that they had been tired since cancer treatment, and among these, 65% reported worsening or no change of fatigue with time. Conclusion: One of four YACSs reported CF 15 years from diagnosis (mean). CF was associated with several possibly treatable factors. Health professionals involved in the follow-up of YACSs should have knowledge of CF and approaches to manage it.

show abstract

“…4 AYA patients differ markedly from older patients with cancer with regard to biological and developmental aspects. 6,7 Being sick with cancer during this sensitive time often results in multiple physical, psychological, and psychosocial limitations such as infertility, 8 changes in physical appearance, 9 fatigue, 10 and disruptions in social life and career. 6,7 Being sick with cancer during this sensitive time often results in multiple physical, psychological, and psychosocial limitations such as infertility, 8 changes in physical appearance, 9 fatigue, 10 and disruptions in social life and career.…”

Section: Introductionmentioning

confidence: 99%

“…5 They are dealing with a serious disease at the time of a complex psychosocial stage in life that includes developmental tasks such as detachment from the parental home, establishing financial and social independence, and the formation of a family, as well as starting a professional career. 6,7 Being sick with cancer during this sensitive time often results in multiple physical, psychological, and psychosocial limitations such as infertility, 8 changes in physical appearance, 9 fatigue, 10 and disruptions in social life and career. 7,9 A recent systematic review by Quinn et al 11 of 35 studies revealed that AYA patients with cancer are more likely to have poorer quality of life (QOL) compared with the age-matched general population.…”

Section: Introductionmentioning

confidence: 99%